John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$297M |
| 2 |
Bank of America
BAC
|
+$249M |
| 3 |
Oracle
ORCL
|
+$247M |
| 4 |
Microsoft
MSFT
|
+$246M |
| 5 |
Snap
SNAP
|
+$243M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$260M |
| 2 |
Merck
MRK
|
+$260M |
| 3 |
S&P Global
SPGI
|
+$233M |
| 4 |
Occidental Petroleum
OXY
|
+$221M |
| 5 |
Walmart Inc
WMT
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.21% |
| 2 | Healthcare | 13.54% |
| 3 | Financials | 11.06% |
| 4 | Industrials | 10.41% |
| 5 | Consumer Discretionary | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
POSCO
PKX
$17.9B
| $784K | ﹤0.01% |
17,600
-41,781
| -70% | -$2.3M |
|
|
TMHC
1627
DELISTED
Taylor Morrison
TMHC
| $784K | ﹤0.01% |
33,561
-199,270
| -86% | -$5.28M |
|
|
SBOW
1628
DELISTED
SilverBow Resources, Inc.
SBOW
| $780K | ﹤0.01% |
27,500
-102,263
| -79% | -$3.74M |
|
|
CSII
1629
DELISTED
Cardiovascular Systems, Inc.
CSII
| $780K | ﹤0.01% |
54,317
-4,308
| -7% | -$74.7K |
|
|
INDT
1630
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
| $777K | ﹤0.01% |
13,088
-3,427
| -21% | -$228K |
|
1631
Skywest
SKYW
$3.95B
| $776K | ﹤0.01% |
36,507
-66,940
| -65% | -$1.76M |
|
|
AZUL
1632
DELISTED
Azul
AZUL
| $775K | ﹤0.01% |
109,100
-140,937
| -56% | -$1.7M |
|
1633
Domo
DOMO
$177M
| $773K | ﹤0.01% |
27,815
-30,860
| -53% | -$1.13M |
|
1634
ThredUp
TDUP
$366M
| $770K | ﹤0.01% |
+308,041
| New | +$1.66M |
|
1635
AMERISAFE
AMSF
$486M
| $767K | ﹤0.01% |
+14,744
| New | +$718K |
|
1636
Wabash National
WNC
$491M
| $767K | ﹤0.01% |
56,511
+37,765
| +201% | +$545K |
|
|
SACH
1637
Sachem Capital Corp
SACH
$42M
| $765K | ﹤0.01% |
187,532
+36,826
| +24% | +$173K |
|
1638
TPG
TPG
$8.67B
| $756K | ﹤0.01% |
31,600
+9,100
| +40% | +$246K |
|
1639
PepGen
PEPG
$231M
| $755K | ﹤0.01% |
+76,000
| New | +$847K |
|
1640
Precigen
PGEN
$2.64B
| $751K | ﹤0.01% |
560,445
-618,533
| -52% | -$918K |
|
|
NWLI
1641
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $751K | ﹤0.01% |
3,707
+780
| +27% | +$160K |
|
1642
Quanex
NX
$919M
| $750K | ﹤0.01% |
+32,962
| New | +$688K |
|
|
BRDG
1643
DELISTED
Bridge Investment Group
BRDG
| $748K | ﹤0.01% |
51,427
+34,490
| +204% | +$613K |
|
|
ENDP
1644
DELISTED
Endo International plc
ENDP
| $748K | ﹤0.01% |
1,607,132
-952,475
| -37% | -$1.21M |
|
|
AMTI
1645
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $747K | ﹤0.01% |
256,829
-112,190
| -30% | -$471K |
|
1646
Sabra Healthcare REIT
SBRA
$5.27B
| $746K | ﹤0.01% |
53,430
+16,700
| +45% | +$223K |
|
|
PHX
1647
DELISTED
PHX Minerals
PHX
| $742K | ﹤0.01% |
244,157
+32,399
| +15% | +$114K |
|
1648
Amphastar Pharmaceuticals
AMPH
$924M
| $738K | ﹤0.01% |
+21,200
| New | +$757K |
|
1649
Ceco Environmental
CECO
$4.24B
| $738K | ﹤0.01% |
123,450
+69,263
| +128% | +$384K |
|
1650
Civista Bancshares
CIVB
$572M
| $738K | ﹤0.01% |
34,717
+1,164
| +3% | +$25.2K |
|
Similar funds
John Overdeck's Q2 2022 Portfolio in Review
As of Q2 2022, John Overdeck held 3,177 positions worth $30.3B, down 11% from $33.9B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.
John Overdeck deployed $2.33B of net new capital in Q2 2022, opening 628 new positions and adding to 764 existing holdings. Its largest new stake was Meta Platforms (Facebook): 1,541,482 shares worth $249M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Merck, an estimated $260M trimmed.
- John Overdeck's largest Q2 2022 buy was Meta Platforms (Facebook): 1,541,482 shares worth $249M.
- John Overdeck added most to Bank of America in Q2 2022, an estimated $249M increase.
- John Overdeck's biggest Q2 2022 reduction was Merck, cutting an estimated $260M.
- John Overdeck fully exited Tesla in Q2 2022, selling an estimated $260M.
- John Overdeck's ten largest holdings make up 8.2% of its $30.3B portfolio in Q2 2022.
- John Overdeck opened 628 new positions and closed 730 in Q2 2022.
- John Overdeck's portfolio value fell 11% quarter-over-quarter to $30.3B.
Based on Two Sigma Investments's 13F filing for Q2 2022, filed 15 Aug 2022.